免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

ADVIA Centaur 布隆氏疱疹病毒-2 IgG

K 號:K181334 · 2018-08-23

申請人Biokit, S.A.
決定日期2018-08-23
產品代碼MYF
諮詢委員會MI (請提供完整的描述文本,以便進行翻譯。)
決定相當於

器材摘要

ADVIA Centaur Herpes-2 IgG is the device name listed in this FDA 510(k) record. The listed applicant is Biokit, S.A.. It received FDA 510(k) clearance on 2018-08-23 under 510(k) number K181334. The device is classified under product code MYF. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ADVIA Centaur Herpes-2 IgG?

ADVIA Centaur Herpes-2 IgG is a medical device that received FDA 510(k) clearance on 2018-08-23. The listed applicant is Biokit, S.A.. The 510(k) number is K181334.

When did ADVIA Centaur Herpes-2 IgG receive FDA 510(k) clearance?

ADVIA Centaur Herpes-2 IgG received FDA 510(k) clearance on 2018-08-23, under 510(k) number K181334.

Who is the listed applicant for ADVIA Centaur Herpes-2 IgG?

The FDA 510(k) record lists Biokit, S.A. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ADVIA Centaur Herpes-2 IgG?

The FDA product code for ADVIA Centaur Herpes-2 IgG is MYF.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Biokit, S.A. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 8 項裝置 →

相關器械(代碼:MYF)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑